News and Insights of 3D Printing and Manufacturing
The University of Wollongong (UOW) will establish a world first facility to enable the development of bioinks and customised bioprinting systems for targeted clinical applications. This will be greatly facilitated by the award of a $400,000 grant from MTPConnect – the Medical Technologies and Pharmaceuticals Industry Growth Centre.
The FDA, the American Food and Drug Administration, has been paying attention to the growth of additive manufacturing for some time now. In order to further provide guidelines to implementing 3D printing of medical devices, promotion their further development and benefits, the US-based institution has developed the first comprehensive guide to provide the Agency’s initial thinking on technical considerations specific to devices using additive manufacturing. The complete guidance is available here to download: FDA AM Guidance
Earlier this week we brought to you an exclusive overview of the leading ceramics-based additive manufacturing processes and systems. In Part 2 of this article, Rachel Park explores the leading materials, services and applications that are breaking through the next 3D printing material frontier.
Ceramics are deeply embedded as a functional material in human history, dating back to Asia as early as 12,000 BC in clay forms for pots. Industrial ceramic materials date back to the start of the 20th Century, and the 1st industrial revolution when ceramics were used more widely for indoor plumbing, sewer tiles, and bathroom and kitchen fixtures.
Stratasys is further advancing the impact and use of 3D printing in medical modeling by signing an agreement with Philips. The agreement includes virtually seamless interfacing and dedicated workflows across Philips IntelliSpace Portal 10 and Stratasys Direct Manufacturing’s parts-on-demand service – allowing a broader range of medical professionals to improve training, research and surgical planning through 3D printing.
At the Radiological Society of North America (RSNA) Annual Meeting and Exhibition, 3D Systems ...
Materialise NV and Siemens Healthineers have joined forces ...
Shining 3D is one of the leading 3D scanning and 3D printing system manufacturer in China. The company has been investing significantly in innovation and now offers a wider range of 3D scanning and 3D printing technologies than any other company in the world. In a Chinese medical 3D printing market that is literally booming, the company is carving a leading role for itself as a provider of 3D solutions to the medical sector – including healthcare, dental and bioprinting applications – with all the challenges that this may bring to a still relatively young company. We spoke with the company’s marketing director Icy Xie about the state and significant growth potential of the Chinese medical 3D printing market as well as the challenges that both Shining 3D and foreign companies may face when addressing this segment.
Dr. Didier Nimal is the founder and CEO of OsseoMatrix. He knows by experience how difficult it is to repair bone losses that range from moderate to severe. He has worked in the medical industry for the Institut Pasteur and then for leading companies in the medical implants sector. He dedicates himself to developing a solution that would be less invasive and less painful for the patient than traditional treatments.
CELLINK and Takara Bio Europe AB will collaborate to evaluate bioprinting of CELLINK’s Bioink with Takara’s cells for insulin secretion by iPS derived beta cells.